A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants

Clinical trial NCT06555601 · TERMINATED

Trial details

NCT number: NCT06555601
Sponsor: UCB Biopharma SRL
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-07-31
Primary completion: 2025-11-24
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.